Intravitreal triamcinolone for uveitic cystoid macular edema: An optical coherence tomography study

Ophthalmology

Volumn 108, Issue 4, 2001, Pages 765-772

  Antcliff, Richard J ^a,b   Spalton, David J ^a   Stanford, Miles R ^a   Graham, Elizabeth M ^a   Fytche, Timothy J ^a   Marshall, John ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAMCINOLONE;

ADULT; ARTICLE; BIOMICROSCOPY; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RISK BENEFIT ANALYSIS; THICKNESS; TRABECULECTOMY; UVEITIS; VISUAL ACUITY; VITRECTOMY;

ADULT; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTERFEROMETRY; INTRAOCULAR PRESSURE; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SOUND; TOMOGRAPHY; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; UVEITIS; VISUAL ACUITY; VITREOUS BODY;

EID: 0035087504     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(00)00658-8     Document Type: Article

References (45)

1. Causes and frequency of blindness in patients with intraocular inflammatory disease
2. Complications of chronic cyclitis
3. Clinical and experimental observations on the use of ACTH and cortisone in ocular inflammatory disease
4. Hydrocortisone in ophthalmology
5. Use of steroids and immunosuppressive drugs in the management of posterior uveitis
6. Orbital floor steroid injections in the treatment of uveitis
7. Cyclosporin in the treatment of severe chronic idiopathic uveitis
8. Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive corticosteroids. A preliminary study
9. Long term results of pars plana vitrectomy in the management of complicated uveitis
10. Immunosuppressive drugs in immune and inflammatory ocular disease
11. Cyclospoin A therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents
12. Randomized, double-masked study of cyclosporine compared to prednisolone in the treatment of endogenous uveitis
13. Macular ischaemia in posterior uveitis
14. The effect of triamcinolone acetonide on a refined experimental model of proliferative vitreoretinopathy
15. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis
16. Intravitreal injection of dexamethasone. Treatment of experimentally induced endophthalmitis
17. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide
18. Inhibition of intraocular proliferations with intravitreal corticosteroids
19. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up
20. Exudative macular degeneration and intravitreal triamcinolone. A pilot study
21. Optical coherence tomography
22. Optical coherence tomography of the human retina
23. Quantitative assessment of macular edema with optical coherence tomography
24. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa
25. Patterns of diabetic macular edema with optical coherence tomography
26. Imaging of macular diseases with optical coherence tomography
27. Pathology of cystoid macular edema
28. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis
29. Topography of diabetic macular edema with optical coherence tomography
30. Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography
31. The interpretation of optical coherence tomography images of the retina
32. The efficacy of systemic corticosteroids in sight-threatening retinal vasculitis
33. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate
34. Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection
35. The lack of toxicity of intravitreally administered triamcinolone acetonide
36. Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation
37. An intravitreal device providing sustained release of cyclosporine and dexamethasone
38. Influence of steroids on fibroblasts. II. The fibroblast as an assay system for topical anti-inflammatory potency of corticosteroids
39. Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations
40. Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study
41. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury
42. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial
43. The neuroprotective pharmacology of methylprednisolone
44. The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis
45. The pathogenesis of edema in diabetic maculopathy